Breckenridge Pharmaceutical, Inc. has announced a voluntary nationwide recall of a batch of Propranolol Hydrochloride Extended-Release Capsules, USP 60 mg in the US over concerns that the medication may contain metal particles.The recall, announced on November 16, 2026, covers one lot of the blood pressure medication manufactured by Adare Pharma Solutions. The company initiated the recall after identifying a possible contamination linked to an intermediate material used in the affected batch.According to the company's recall notice, the contaminated material was suspected to be the source of metal contamination identified in a separate lot that was not released into the market.Risk Of Injuries To The Digestive TractThe company has warned that taking capsules from the affected lot could cause physical injuries to soft tissues in the body.According to the recall notice, use of the affected product could cause "lacerations of soft tissues in the oral cavity, esophagus, stomach, or intestine."However, Breckenridge Pharmaceutical stated that it was not aware of any adverse events related to the recall at the time of the announcement.The affected products were distributed to wholesalers and pharmacies across the US between October 26 and November 4, 2026.Also read: From 4 To 100 Kratom Capsules A Day: Woman Shares Warning Signs Of AddictionWhich Propranolol Batch Has Been Recalled?The recall is limited to a specific batch of 60 mg Propranolol Hydrochloride Extended-Release Capsules. The details are:Product: Propranolol Hydrochloride Extended-Release Capsules, USP, 60 mgPackage size: 100-count bottleNDC number: 51991-817-01Affected lot number: PK25110035Expiry date: May 2029Those who have been prescribed the pill between the dates mentioned above are advised to check the product packaging and lot number to determine whether their medication is part of the recall.Also read: Popular Anti-Anxiety Capsules Recalled Over Salmonella Fears: What Should Patients KnowWhat Should Patients Do?Breckenridge Pharmaceutical has advised consumers to immediately stop taking the medication from the affected lot and contact their physician or healthcare provider for medical advice for obtaining a replacement."Consumers should return any unused portion of the affected product to the pharmacy where it was obtained," the company's announcement said.Patients should also return any unused capsules from the recalled batch to the pharmacy where they purchased the medication. Anyone who has experienced health problems that could be due to the recalled medicine should contact their healthcare provider.Pharmacies, wholesalers and other retailers have been instructed to check their inventories, quarantine the affected products and stop distributing or dispensing them.Consumers seeking additional information about the recall can contact Qualanex, the company's designated recall service provider, at 1-855-736-0807 or email recall@qualanex.com. The recall is being conducted with the knowledge of the US Food and Drug Administration (FDA).Also read: US FDA Recalls Thousands Of Blood Pressure Drugs Over Excess Drug Levels, Failed Quality TestsWhat Is Propranolol Used For?Propranolol belongs to a class of medicines called beta-blockers. It works by reducing the effects of certain stress hormones on the heart, thereby slowing the heart rate and reducing blood pressure.The medication is commonly prescribed to manage high blood pressure and other cardiovascular conditions. It is also used for certain heart rhythm disorders, angina and migraine prevention.The extended-release formulation is designed to release the medicine gradually over time, allowing effects that last long.Propranolol's recall is the latest in a series of recent blood pressure medication recalls, including a recent one involving Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide tablets. They were recalled as they did not dissolve properly. A while go, Chlorthalidone tablets were also recalled for the same reason.